✦ LIBER ✦

Pharmacodynamics of ceftriaxone and cefixime against community-acquired respiratory tract pathogens

✍ Scribed by Robert C. Owens Jr.; Pamela Tessier; Charles H. Nightingale; Paul G. Ambrose; Richard Quintiliani; David P. Nicolau

Book ID: 119563227
Publisher: Elsevier Science
Year: 2001
Tongue: English
Weight: 221 KB
Volume: 17
Category: Article
ISSN: 0924-8579
DOI: 10.1016/s0924-8579(01)00322-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PP-209 In vitro efficacy of ceftriaxone

PP-209 In vitro efficacy of ceftriaxone and cefixime against respiratory pathogens

✍ F. Kaleem; J. Usman; A. Hassan 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 42 KB

Pharmacodynamics of Fluoroquinolones aga

Pharmacodynamics of Fluoroquinolones against Streptococcus pneumoniae in Patients with Community-Acquired Respiratory Tract Infections

✍ Ambrose, P. G.; Grasela, D. M.; Grasela, T. H.; Passarell, J.; Mayer, H. B.; Pie 📂 Article 📅 2001 🏛 American Society for Microbiology 🌐 English ⚖ 171 KB

Activity of temafloxacin and other fluor

Activity of temafloxacin and other fluoroquinolones against typical and atypical community-acquired respiratory tract pathogens

✍ Dwight J. Hardy 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 340 KB

Comparative activity of telithromycin ag

Comparative activity of telithromycin against typical community-acquired respiratory pathogens

✍ Buxbaum, A. 📂 Article 📅 2003 🏛 Oxford University Press 🌐 English ⚖ 94 KB

In VitroandIn VivoActivity of Moxifloxac

In VitroandIn VivoActivity of Moxifloxacin against Community Respiratory Tract Pathogens

✍ J. M. Blondeau, D. Felmingham 📂 Article 📅 1999 🏛 Springer International Publishing AG 🌐 English ⚖ 328 KB

Population pharmacokinetics and pharmaco

Population pharmacokinetics and pharmacodynamics of sitafloxacin in patients with community-acquired respiratory tract infections

✍ Tanigawara, Yusuke; Kaku, Mitsuo; Totsuka, Kyoichi; Tsuge, Hiroyuki; Saito, Atsu 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 484 KB